This result was consistent with the molecular genetics classification, because KMT2A-r is more common in the Pro-B ALL, while TCF3::PBX1 rearrangement is more common in the Pre-B ALL. The gene discussed is TCF3; the disease is acute lymphoblastic leukemia.